Toxicity Profile of Antibody-Drug Conjugates in Breast Cancer: Practical Considerations
July 2023
in “
EClinicalMedicine
”
Studysummary This review discusses the toxicities associated with antibody-drug conjugates in breast cancer treatment and proposes strategies for monitoring and managing these adverse effects, but it reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on thelancet.com →